Global CBD Consumer Health Market by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online, Retail Pharmacies, Retail Stores) - Forecast 2023-2030
08 mars 2024 09h31 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global CBD Consumer Health Market by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online, Retail Pharmacies, Retail Stores) -...
U.S. Controlled Substance Market Size Worth USD 74.3 billion by 2031, Rising at a CAGR of 5.2% - Says Transparency Market Research
07 sept. 2023 15h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The U.S. controlled substance market is projected to flourish at a CAGR of 5.2% from 2022...
Wake Up Narcolepsy Debuts Public Service Announcement in Collaboration with Red Square Pictures
11 juil. 2023 11h17 HE
|
Wake Up Narcolepsy
WORCESTER, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Wake Up Narcolepsy (WUN), a national leader for research and awareness, premiered its Narcolepsy public service announcement in partnership with Red...
Remote Patient Monitoring Market’s expected worth by 2030 is USD 4.07 billion
28 juin 2022 13h05 HE
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 28, 2022 (GLOBE NEWSWIRE) -- The key factors driving the Remote Patient Monitoring Market are the rising number of chronic diseases, increased awareness and a rising...
KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
30 mars 2022 16h05 HE
|
KemPharm
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, March 30, 2022, 5:00 p.m. ET Corporate and Regulatory Highlights Announced strategic focus on developing...
KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
21 mars 2022 07h30 HE
|
KemPharm
Data demonstrate higher doses of SDX were generally well-tolerated and produced targeted pharmacodynamic effects that may be beneficial for the treatment of idiopathic hypersomnia (IH) and other sleep...
Sleep Disorder Market revenue to cross USD 20.5 Bn by 2027: Global Market Insights Inc.
12 janv. 2022 06h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The sleep disorder market size is anticipated to record a valuation of USD 20.5 billion by 2027, according to the most recent study by...
College of DuPage Student Awarded Honors Council of the Illinois Region Research Grant to Study Rare Sleep Disorder
16 juin 2020 10h05 HE
|
College of DuPage
Glen Ellyn, Ill., June 16, 2020 (GLOBE NEWSWIRE) -- College of DuPage Psychology student Savannah Santos was recently awarded a $600 Margaret Messer Student Research Grant from the Honors Council of...
Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep Disorders
07 nov. 2017 09h00 HE
|
CURE Pharmaceutical; Therapix Biosciences Ltd.
OXNARD, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cure Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology announced today that it has entered into a product...
Zynex Announces First Quarter 2015 Results
12 mai 2015 08h00 HE
|
Zynex, Inc.
LONE TREE, CO--(Marketwired - May 12, 2015) - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain...